 REDWOOD CITY, Calif., April 7, 2021 PRNewswire -- Nevro Corp. NYSE: NVRO, a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the company will report its financial results for the first quarter ended March 31, 2021 after the market closes on May 5, 2021. 